Effects of intravenous immunoglobulin on clinical and immunological findings of patients with humoral immunodeficiency diseases

We evaluated nine patients with humoral immunodeficiency (6 immunodeficiency with hyper-IgM, 2 X-linked agammaglobulinemia, 1 common variable immunodeficiency) who were being treated with intravenous immunoglobulins (IVIG). After the use of the IVIG regimen in a dose of 250-300 mg/kg/4 weeks...

Olles dieđut

Bibliográfalaš dieđut
Váldodahkkit: F Ersoy, I Tezcan, O Sanal
Materiálatiipa: Artihkal
Giella:English
Almmustuhtton: Hacettepe University Institute of Child Health 1992-10-01
Ráidu:The Turkish Journal of Pediatrics
Liŋkkat:https://turkjpediatr.org/article/view/3735